Related references
Note: Only part of the references are listed.GC-MS metabolomics-based approach for the identification of a potential VOC-biomarker panel in the urine of renal cell carcinoma patients
Marcia Monteiro et al.
JOURNAL OF CELLULAR AND MOLECULAR MEDICINE (2017)
Investigation of urinary volatomic alterations in head and neck cancer: a non-invasive approach towards diagnosis and prognosis
Ravindra Taware et al.
METABOLOMICS (2017)
Volatile metabolomic signature of human breast cancer cell lines
Catarina L. Silva et al.
SCIENTIFIC REPORTS (2017)
Cancer Statistics, 2017
Rebecca L. Siegel et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2017)
Determination of volatile organic compounds exhaled by cell lines derived from hematological malignancies
Hongxia Tang et al.
BIOSCIENCE REPORTS (2017)
Metabolomic Biomarkers of Prostate Cancer: Prediction, Diagnosis, Progression, Prognosis, and Recurrence
Rachel S. Kelly et al.
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION (2016)
Volatile organic compounds as new biomarkers for colorectal cancer: a review
M. Di Lena et al.
COLORECTAL DISEASE (2016)
Response of Degarelix treatment in human prostate cancer monitored by HR-MAS 1H NMR spectroscopy
Basetti Madhu et al.
METABOLOMICS (2016)
Acidic extracellular pH promotes prostate cancer bone metastasis by enhancing PC-3 stem cell characteristics, cell invasiveness and VEGF-induced vasculogenesis of BM-EPCs
Sheng Huang et al.
ONCOLOGY REPORTS (2016)
From sample treatment to biomarker discovery: A tutorial for untargeted metabolomics based on GC-(EI)-Q-MS
Annalaura Mastrangelo et al.
ANALYTICA CHIMICA ACTA (2015)
Genomic Predictors of Outcome in Prostate Cancer
Peter J. Bostrom et al.
EUROPEAN UROLOGY (2015)
Effects of culture media on metabolic profiling of the human gastric cancer cell line SGC7901
Zicheng Huang et al.
MOLECULAR BIOSYSTEMS (2015)
Urinary Volatile Organic Compounds for the Detection of Prostate Cancer
Tanzeela Khalid et al.
PLOS ONE (2015)
Sampling and analysis of metabolomes in biological fluids
Maria Jose Nunes de Paiva et al.
ANALYST (2014)
Metabolomics in cell culture-A strategy to study crucial metabolic pathways in cancer development and the response to treatment
Anna Halama
ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS (2014)
Aldehyde dehydrogenase 3A1 associates with prostate tumorigenesis
J. Yan et al.
BRITISH JOURNAL OF CANCER (2014)
Unique volatolomic signatures of TP53 and KRAS in lung cells
M. P. A. Davies et al.
BRITISH JOURNAL OF CANCER (2014)
Assessment, origin, and implementation of breath volatile cancer markers
Hossam Haick et al.
CHEMICAL SOCIETY REVIEWS (2014)
Investigation of potential breath biomarkers for the early diagnosis of breast cancer using gas chromatography-mass spectrometry
Jie Li et al.
CLINICA CHIMICA ACTA (2014)
Analysis of volatile human urinary metabolome by solid-phase microextraction in combination with gas chromatography-mass spectrometry for biomarker discovery: Application in a pilot study to discriminate patients with renal cell carcinoma
Marcia Monteiro et al.
EUROPEAN JOURNAL OF CANCER (2014)
Feasibility of Detecting Prostate Cancer by Ultraperformance Liquid Chromatography-Mass Spectrometry Serum Metabolomics
Xiaoling Zang et al.
JOURNAL OF PROTEOME RESEARCH (2014)
Application of an Electronic Nose in the Diagnosis of Head and Neck Cancer
Nicoline Leunis et al.
LARYNGOSCOPE (2014)
Identification of Volatile Biomarkers of Gastric Cancer Cells and Ultrasensitive Electrochemical Detection based on Sensing Interface of Au-Ag Alloy coated MWCNTs
Yixia Zhang et al.
THERANOSTICS (2014)
Selected Ion Flow Tube Mass Spectrometry Analysis of Exhaled Breath for Volatile Organic Compound Profiling of Esophago-Gastric Cancer
Sacheen Kumar et al.
ANALYTICAL CHEMISTRY (2013)
Exhaled volatile organic compounds identify patients with colorectal cancer
D. F. Altomare et al.
BRITISH JOURNAL OF SURGERY (2013)
Release and uptake of volatile organic compounds by human hepatocellular carcinoma cells (HepG2) in vitro
Pawel Mochalski et al.
CANCER CELL INTERNATIONAL (2013)
New Opportunities from the Cancer Metabolome
Omran Abu Aboud et al.
CLINICAL CHEMISTRY (2013)
Mammalian cell metabolomics: Experimental design and sample preparation
Zacarias Leon et al.
ELECTROPHORESIS (2013)
Volatile biomarkers from human melanoma cells
Jae Kwak et al.
JOURNAL OF CHROMATOGRAPHY B-ANALYTICAL TECHNOLOGIES IN THE BIOMEDICAL AND LIFE SCIENCES (2013)
Comparative analysis of volatile metabolomics signals from melanoma and benign skin: a pilot study
T. Abaffy et al.
METABOLOMICS (2013)
HMDB 3.0-The Human Metabolome Database in 2013
David S. Wishart et al.
NUCLEIC ACIDS RESEARCH (2013)
Cell Metabolomics
Aihua Zhang et al.
OMICS-A JOURNAL OF INTEGRATIVE BIOLOGY (2013)
Metabolic Reprogramming and Validation of Hyperpolarized 13C Lactate as a Prostate Cancer Biomarker Using a Human Prostate Tissue Slice Culture Bioreactor
Kayvan R. Keshari et al.
PROSTATE (2013)
Screening for Prostate Cancer: US Preventive Services Task Force Recommendation Statement
Virginia A. Moyer
ANNALS OF INTERNAL MEDICINE (2012)
Volatile Organic Compounds of Lung Cancer and Possible Biochemical Pathways
Meggie Hakim et al.
CHEMICAL REVIEWS (2012)
Aldehyde dehydrogenases and cell proliferation
G. Muzio et al.
FREE RADICAL BIOLOGY AND MEDICINE (2012)
Effect size estimation: Methods and examples
Lut Berben et al.
INTERNATIONAL JOURNAL OF NURSING STUDIES (2012)
GC/MS-based metabolomic approach to validate the role of urinary sarcosine and target biomarkers for human prostate cancer by microwave-assisted derivatization
Hao Wu et al.
ANALYTICAL AND BIOANALYTICAL CHEMISTRY (2011)
The scent of disease: volatile organic compounds of the human body related to disease and disorder
Mika Shirasu et al.
JOURNAL OF BIOCHEMISTRY (2011)
Application of metabolomics to prostate cancer
Bruce J. Trock
UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS (2011)
Metabolomics: A Novel Approach to Early and Noninvasive Prostate Cancer Detection
Matthew J. Roberts et al.
KOREAN JOURNAL OF UROLOGY (2011)
MZmine 2: Modular framework for processing, visualizing, and analyzing mass spectrometry-based molecular profile data
Tomas Pluskal et al.
BMC BIOINFORMATICS (2010)
Detection of lung, breast, colorectal, and prostate cancers from exhaled breath using a single array of nanosensors
G. Peng et al.
BRITISH JOURNAL OF CANCER (2010)
Analysis of volatile organic compounds (VOCs) in the headspace of NCI-H1666 lung cancer cells
Andreas Sponring et al.
CANCER BIOMARKERS (2010)
Cell culture metabolomics: applications and future directions
Miroslava Cuperlovic-Culf et al.
DRUG DISCOVERY TODAY (2010)
Sarcosine in Urine after Digital Rectal Examination Fails as a Marker in Prostate Cancer Detection and Identification of Aggressive Tumours
Florian Jentzmik et al.
EUROPEAN UROLOGY (2010)
Identification of Novel Truncated Androgen Receptor (AR) Mutants Including Unreported Pre-mRNA Splicing Variants in the 22Rv1 Hormone-Refractory Prostate Cancer (PCa) Cell Line
Gemma Marcias et al.
HUMAN MUTATION (2010)
Application of Similarity Coefficients to Predict Disease Using Volatile Organic Compounds
Steve Smith et al.
IEEE SENSORS JOURNAL (2010)
Determination of aldehydes in exhaled breath of patients with lung cancer by means of on-fiber-derivatisation SPME-GC/MS
Diana Poli et al.
JOURNAL OF CHROMATOGRAPHY B-ANALYTICAL TECHNOLOGIES IN THE BIOMEDICAL AND LIFE SCIENCES (2010)
Overdetection, overtreatment and costs in prostate-specific antigen screening for prostate cancer
E. A. M. Heijnsdijk et al.
BRITISH JOURNAL OF CANCER (2009)
Release of volatile organic compounds (VOCs) from the lung cancer cell line CALU-1 in vitro
Wojciech Filipiak et al.
Cancer Cell International (2009)
Mortality Results from a Randomized Prostate-Cancer Screening Trial
Gerald L. Andriole et al.
NEW ENGLAND JOURNAL OF MEDICINE (2009)
Screening and Prostate-Cancer Mortality in a Randomized European Study
Fritz H. Schroeder et al.
NEW ENGLAND JOURNAL OF MEDICINE (2009)
HMDB: a knowledgebase for the human metabolome
David S. Wishart et al.
NUCLEIC ACIDS RESEARCH (2009)
3-Heptanone as a potential new marker for valproic acid therapy
S. Erhart et al.
JOURNAL OF BREATH RESEARCH (2009)
Pathologic Characteristics of Cancers Detected in the Prostate Cancer Prevention Trial: Implications for Prostate Cancer Detection and Chemoprevention
M. Scott Lucia et al.
CANCER PREVENTION RESEARCH (2008)
Determination of volatile products of human colon cell line metabolism by GC/MS analysis
Dunja Zimmermann et al.
METABOLOMICS (2007)
HMDB: the human metabolome database
David S. Wishart et al.
NUCLEIC ACIDS RESEARCH (2007)
Use of 2.6 Ng/Ml prostate specific antigen prompt for biopsy in men older than 60 years
RB Nadler et al.
JOURNAL OF UROLOGY (2005)
Metabolic footprinting and systems biology: The medium is the message
DB Kell et al.
NATURE REVIEWS MICROBIOLOGY (2005)
Characterizing prostatic adenocarcinomas in men with a serum prostate specific antigen level of <4.0 ng/mL
MH Sokoloff et al.
BJU INTERNATIONAL (2004)
The influence of finasteride on the development of prostate cancer
IM Thompson et al.
NEW ENGLAND JOURNAL OF MEDICINE (2003)
Comparison of percent free PSA, PSA density, and age-specific PSA cutoffs for prostate cancer detection and staging
WJ Catalona et al.
UROLOGY (2000)
Share Paper
